— Know what they know.
Not Investment Advice

VYND OTC

Vynleads, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +29.6% 1Y: -18.0% 3Y: +49.0% 5Y: -45.4%
$0.41
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 42 · $7.5M mcap · 9M float · 0.0007% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$15K +58.1% ▲
Operating Income
-$239K -1.5% ▼
Net Income
-$261K +0.9% ▲
EPS (Diluted)
$-0.02 +10.1% ▲
EBITDA
-$239K -1.5% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$48K$484$49$0$0
YoY Growth-87.8%-99.0%-89.9%-100.0%+0.0%
Cost of Revenue$57K$32K$29K$36K$15K
Gross Profit-$8K-$32K-$29K-$36K-$15K
Gross Margin-17.5%-6608.1%-59485.7%——
R&D Expenses$0$0$0$0$0
SG&A Expenses$364K$235K$232K$200K$224K
Operating Expenses$362K$235K$232K$200K$224K
Operating Income-$372K-$267K-$261K-$236K-$239K
Operating Margin-771.4%-55118.4%-533159.2%——
Interest Expense$8K$11K$14K$26K$24K
Income Before Tax-$378K-$272K-$271K-$262K-$259K
Tax Expense$1K$0$3K$2K$3K
Net Income-$380K-$283K-$274K-$263K-$261K
Net Margin-786.6%-58396.5%-558414.3%——
EPS (Diluted)$-0.03$-0.02$-0.02$-0.02$-0.02
EBITDA-$368K-$254K-$254K-$236K-$239K
Shares Outstanding11M12M12M12M13M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms